iProov vs Malwarebytes
Side-by-side comparison of AI visibility scores, market position, and capabilities
iProov surpassed 1M daily verifications in 2025; first biometrics vendor certified to NIST 800-63-4; raised $85.1M total; serves U.S. DHS, UK Home Office, GovTech Singapore, ING, and UBS.
About
iProov is a London-based biometric identity verification company founded in 2011 by Andrew Bud. The company specializes in face biometric authentication with a focus on genuine presence assurance — verifying not just that a face matches an identity document, but that the person is physically present, alive, and not presenting a digital attack such as a deepfake, photo replay, or 3D mask. Its flagship technology, Genuine Presence Assurance (GPA), uses a proprietary illumination-based liveness detection approach that is highly resistant to injection attacks and synthetic media manipulation.
Malwarebytes is an endpoint protection platform offering malware detection, remediation, and EDR for consumers, SMBs, and enterprises across Windows, Mac, and mobile.
About
Malwarebytes is a cybersecurity company headquartered in Santa Clara, California that provides endpoint protection, detection, and response software to consumers, small and midsize businesses, and enterprises. Founded in 2008, Malwarebytes originally built its reputation as a best-in-class malware remediation tool used to clean up infections that traditional antivirus software had missed — a positioning that grew a massive consumer user base and established the brand as a trusted remediation authority. The company subsequently expanded its product line from a standalone remediation utility to a full endpoint protection platform capable of replacing traditional antivirus, and has extended into EDR, DNS filtering, and incident response capabilities for business customers who need more than reactive cleanup.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.